PositoAI/ JP/ MedRx Co., Ltd

MedRx Co., Ltd

Tokyo: 4586 · Healthcare

Positivity Index

#6,460 / 10,750

Global

#2,988 / 3,683

Japan

Positivity Score

20,730

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: not checked yet

MedRx Co., Ltd — Overview & Financial Snapshot

MedRx Co., Ltd (Tokyo: 4586) is a Healthcare company, ranked #6,460 of 10,750 companies globally and #2,988 of 3,683 in Japan on PositoAI, with a Positivity Score of 20,730. Its market capitalisation is ₹196.01 Cr (¥3.24B), P/E ratio is -3.5 and P/B ratio is 2.04. Red flags (PosiRed) are not checked yet for companies in this market.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Wel-Dish.Incorporated 27,767 #16 Kohjin Bio Co., Ltd. 25,987 #40 MTI Ltd. 25,486 #50 GIMIC Co., Ltd. 25,357 #53 PhoenixBio Co., Ltd. 25,318

— Nothing to show —

OpenAI is reading recent news...

MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops transdermal medicines based on the ionic liquid transdermal system (ILTS) and the nano-sized colloid transdermal system (NCTS); and microneedle arrays/patch vaccines for the delivery of vaccines and APIs through the skin. Its products also include MRX-5LBT, which has NDA approval in the United States for neuropathic pain; MRX-4TZT, which is in a Phase II trial for spastic paralysis; Alto-101, which is in a Phase II trial for schizophrenia; MRX-9FLT, which is in a Phase I trial for moderate to severe pain; and MRX-6LDT, which is in a drug formulation development stage for chronic pain. MedRx Co., Ltd was incorporated in 2002 and is headquartered in Higashikagawa, Japan.

P/B Ratio 2.04

P/E Ratio -3.5

D/E Ratio 0.00

ROE -49.61%

Owes vs Owns ? 0.09× Low ¥0.09 owed for every ¥1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-8.39¥-13.89

Forward EPS —

Beta 0.60

Market Cap ₹196.01 Cr¥3.24B

What these numbers mean →

What does MedRx Co., Ltd do?

What is MedRx Co., Ltd's P/E and P/B ratio?

MedRx Co., Ltd has a P/E ratio of -3.5 and a P/B ratio of 2.04.

What is MedRx Co., Ltd's debt-to-equity ratio?

MedRx Co., Ltd has a debt-to-equity ratio of 0.00.

How much does MedRx Co., Ltd owe compared with what it owns?

MedRx Co., Ltd owes ¥0.09 for every ¥1 it owns (balance sheet Jun 2026), which is low.

What is MedRx Co., Ltd's Positivity rank?

MedRx Co., Ltd is ranked #6,460 of 10,750 companies globally and #2,988 of 3,683 in Japan on PositoAI, with a Positivity Score of 20,730.

Does MedRx Co., Ltd have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for MedRx Co., Ltd.

Where can I read the latest news about MedRx Co., Ltd?

Recent headlines about MedRx Co., Ltd from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does MedRx Co., Ltd have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of MedRx Co., Ltd's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.